SE9201281D0 - NEW HUMAN MONOCLONAL ANTIBODIES, AND A METHOD FOR PREPARATION THEREOF - Google Patents

NEW HUMAN MONOCLONAL ANTIBODIES, AND A METHOD FOR PREPARATION THEREOF

Info

Publication number
SE9201281D0
SE9201281D0 SE9201281A SE9201281A SE9201281D0 SE 9201281 D0 SE9201281 D0 SE 9201281D0 SE 9201281 A SE9201281 A SE 9201281A SE 9201281 A SE9201281 A SE 9201281A SE 9201281 D0 SE9201281 D0 SE 9201281D0
Authority
SE
Sweden
Prior art keywords
preparation
human monoclonal
monoclonal antibodies
new human
antibodies
Prior art date
Application number
SE9201281A
Other languages
Swedish (sv)
Other versions
SE9201281L (en
Inventor
C Borrebaeck
Original Assignee
Bioinvent Int Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinvent Int Ab filed Critical Bioinvent Int Ab
Priority to SE9201281A priority Critical patent/SE9201281L/en
Publication of SE9201281D0 publication Critical patent/SE9201281D0/en
Priority to PCT/SE1993/000343 priority patent/WO1993021952A1/en
Priority to AU42742/93A priority patent/AU4274293A/en
Publication of SE9201281L publication Critical patent/SE9201281L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

New human monoclonal antibodies with neutralizing activity against the cytomegalovirus (CMV). A method for preparation of such antibodies is also described, whereby the antibodies are produced from human peripheral blood lymphocytes. The antibodies are specific for epitopes between aa 552-635 of gp58 or aa 67-86 of gp116 and recognize native gp58/gp116 as well.
SE9201281A 1992-04-23 1992-04-23 Novel human monoclonal antibodies and process for their preparation SE9201281L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9201281A SE9201281L (en) 1992-04-23 1992-04-23 Novel human monoclonal antibodies and process for their preparation
PCT/SE1993/000343 WO1993021952A1 (en) 1992-04-23 1993-04-21 Human monoclonal antibodies against cytomegalovirus and method for preparation thereof
AU42742/93A AU4274293A (en) 1992-04-23 1993-04-21 Human monoclonal antibodies against cytomegalovirus and method for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201281A SE9201281L (en) 1992-04-23 1992-04-23 Novel human monoclonal antibodies and process for their preparation

Publications (2)

Publication Number Publication Date
SE9201281D0 true SE9201281D0 (en) 1992-04-23
SE9201281L SE9201281L (en) 1993-10-24

Family

ID=20386038

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201281A SE9201281L (en) 1992-04-23 1992-04-23 Novel human monoclonal antibodies and process for their preparation

Country Status (3)

Country Link
AU (1) AU4274293A (en)
SE (1) SE9201281L (en)
WO (1) WO1993021952A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756214C1 (en) * 1997-12-17 1999-02-25 Biotest Ag New chimeric human cytomegalovirus (HCMV) polypeptides
DE60329526D1 (en) 2002-11-15 2009-11-12 Morphotek Inc METHOD OF GENERATING HIGH ANTIBODY PRODUCTION OF HYBRIDOMAS RESULTING FROM IN VITRO IMMUNIZATION
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
WO2009024445A1 (en) * 2007-08-22 2009-02-26 Ribovax Biotechnologies Sa Antibodies against human cytomegalovirus (hcmv)
JP5544309B2 (en) 2008-03-10 2014-07-09 セラクローン サイエンシーズ， インコーポレイテッド Compositions and methods for treatment and diagnosis of cytomegalovirus infection
EP3178845A1 (en) 2008-07-16 2017-06-14 Institute for Research in Biomedicine Human cytomegalovirus neutralizing antibodies and use thereof
EP2420572B1 (en) 2009-04-01 2015-03-25 Evec Incorporated Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
SG181901A1 (en) 2009-12-23 2012-08-30 4Antibody Ag Binding members for human cytomegalovirus
US20150152166A1 (en) * 2013-04-19 2015-06-04 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of cytomegalovirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910000736B1 (en) * 1985-12-06 1991-02-06 데이진 가부시키가이샤 Anticytomegalo virus human monoclonal antibody and process for its preparation

Also Published As

Publication number Publication date
WO1993021952A1 (en) 1993-11-11
SE9201281L (en) 1993-10-24
AU4274293A (en) 1993-11-29

Similar Documents

Publication Publication Date Title
AU648506B2 (en) Erythropoietin (EPO) peptides and antibodies directed against these
ATE512224T1 (en) RECONSTITUTED HUMAN ANTI-HM.1 ANTIBODIES
NO970221D0 (en) Human neutralizing monoclonal antibodies against human immunodeficiency virus
AU2349697A (en) Monoclonal antibodies against the interferon receptor with neutralizing activity against type I interferon
PT941121E (en) LIPOPILIZED PHARMACEUTICAL PREPARATIONS, STABLE, OF MONOCLONAL OR POLYCLONAL ANTIBODIES
ATE233814T1 (en) HUMAN NEUTRALIZING MONOCLONAL ANTIBODY AGAINST THE VIRUS THAT CAUSES HUMAN IMMUNE DEFICIENCY
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
EP0314402A3 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ES2133139T3 (en) BISPECIFIC ANTIBODIES HETERO WITH DOUBLE EFFECTIVE FUNCTIONS.
KR890002547A (en) Monoclonal antibodies and peptides for the treatment and diagnosis of HIV infection
NO910209L (en) PROCEDURE FOR THE PREPARATION OF RECOMBINANT HUMAN ANTI-CD18 ANTIBODIES.
NO870476D0 (en) PROCEDURE FOR THE PREPARATION OF CROSS PROTECTIVE HUMAN MONOCLONAL ANTIBODY PREPARATIONS.
SE9201281D0 (en) NEW HUMAN MONOCLONAL ANTIBODIES, AND A METHOD FOR PREPARATION THEREOF
CA2008817A1 (en) M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
AU7203194A (en) Bispecific human monoclonal antibodies specific for human immunodeficiency virus
MX9301858A (en) RECOMBINANT HIV-HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF HIV INFECTION.
AU2133292A (en) Hcmv-specific peptides, agents therefor and the use thereof
KR890700683A (en) Methods for searching for antibodies against human immunodeficiency virus
DK69690A (en) HUMAN ANTI-RH (D) MONOCLONAL ANTIBODIES
NO883603L (en) HUMAN MONOCLONAL ANTIBODIES AND PROPHYLACTIC AND THERAPEUTIC AGENTS FOR INFECTIOUS DISEASES INCLUDING THESE EFFECTIVE COMPONENT.
NO874107L (en) NEW MONOCLONAL ANTIBODIES AGAINST IFN-WAA, PROCEDURE FOR PRODUCING THEREOF AND APPLICATION FOR PURIFICATION AND DETECTION OF IFN-OMEGA.
DE376770T1 (en) USE OF HUMAN IMMUNOGLOBULIN G OR FC FRAGMENTS, LIKE PREPARATORY MEDICINES FOR THE ADMINISTRATION OF MONOCLONAL ANTIBODIES TO HUMANS.
AU582129B2 (en) Circulating antigens of dirofilaria immitis,monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens
EP0334076A3 (en) Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9201281-4